• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,471.95
    176.40 (+0.31%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,560.35(%)
  • Trent
    2,815.00 3,507.32(%)
  • Raymond
    1,024.00 869.05(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 521.75(%)
  • One 97
    1,829.50 1,759.05(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,673.50(%)
  • Britannia Inds.
    4,946.05 5,000.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Indoco Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 12579.0
  • ISIN : INE873D01024
254.25 23 (9.98%)
  • As on 11 Sep 2026 (EOD)

  • Today’s Low

    229.00

  • Today’s High

    269.90

  • Open

    234.94

  • Perv Close

    231.18

  • 52W Low

    162.19

  • 52W High

    332.20

Key Indicators

  • P/E(TTM)

    109.03

  • Mar.Cap (₹Cr.)

    2,346.82

  • Div & Yield %

    0.08

  • Book Value(₹)

    119.08

  • Debt-Equity Ratio

    9.98

  • AGM Date

    10-Sep-2026

  • EPS

    2.33

  • P/E Ratio

    109.03

Financials Ratios

  • Debt-Equity Ratio

    0.47

  • Mar.Cap (₹Cr.)

    2,346.82

  • RONW (%)

    9.07

  • ROCE (%)

    10.76

Score Board

  • Equity (₹ in Cr.)

    18.46

  • BV (₹)

    119.10

  • Sales( ₹ in Cr.)

    1,686.07

  • NP (in Cr.)

    -3.05

  • NP Var(%)

    70.0

  • Div%

    10.0

  • CPS (₹)

    11.30

  • EPS (₹)

    -0.30

  • Traded Value (₹ in Lakhs)

    2,344.97

  • 52 Week High

    332.20

  • 52 Week Low

    162.19

  • Price BSE

    254.0

  • Price NSE

    254.00

  • Market Capital( in Cr.)

    2,344.97

  • P/C Ratio

    22.60

  • P/E Ratio

    -767.60

  • Price Vs.BV

    -0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,686.07 1,518.19 1,790.81 1,666.69 1,539.72 1,240.30
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,686.07 1,518.19 1,790.81 1,666.69 1,539.72 1,240.30
Other Income 33.10 19.48 28.24 2.33 2.32 3.11
Stock Adjustments -7.20 32.04 14.70 -6.55 26.30 12.13
Total Income 1,711.97 1,569.71 1,833.75 1,662.47 1,568.34 1,255.54
EXPENDITURE :            
Raw Materials 493.35 475.72 561.15 514.74 483.05 366.20
Power and Fuel Cost 55.44 53.45 55.31 50.61 42.78 36.89
Employee Cost 393.63 368.74 350.55 321.15 294.95 272.88
Other Manufacturing Expenses 104.33 91.60 116.72 89.70 60.66 46.07
Selling and Administration Expenses 387.62 387.49 407.12 340.26 293.42 258.53
Miscellaneous Expenses 93.66 45.19 64.86 58.79 64.15 48.29
Employee Benefit Expenses 393.63 368.74 350.55 321.15 294.95 272.88
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,528.03 1,422.19 1,555.72 1,375.25 1,239.02 1,028.86
Operating Profit 183.95 147.50 278.02 287.22 329.32 226.69
Interest 88.50 56.63 36.81 25.03 14.14 22.22
Gross Profit 95.45 90.87 241.21 262.19 315.18 204.47
Depreciation 106.90 98.25 87.98 70.60 78.95 73.12
Profit Before Tax -11.45 -7.38 153.23 191.59 236.23 131.35
Current Tax 2.92 0.00 32.77 55.20 93.23 38.47
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -8.73 1.36 3.81 -4.97 -11.52 0.48
Reported Net Profit -5.63 -8.74 116.64 141.36 154.52 92.39
Extraordinary Items -2.58 1.36 8.49 -0.90 -0.31 -0.17
Adjusted Net Profit -3.05 -10.10 108.15 142.26 154.83 92.56
Adjustment below Net Profit 1.33 -4.49 0.04 1.44 -5.33 -0.86
P & L Balance brought forward 754.44 781.49 685.55 563.48 428.11 339.35
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.85 13.83 20.73 20.73 13.82 2.76
P & L Balance carried down 748.29 754.44 781.49 685.55 563.48 428.11
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 75.00 112.50 112.50 75.00
Dividend Per Share(Rs) 0.20 0.20 1.50 2.25 2.25 1.50
Earnings Per Share-Unit Curr -0.61 -0.95 12.65 15.34 16.77 10.03
Earnings Per Share(Adj)-Unit Curr -0.61 -0.95 12.65 15.34 16.77 10.03
Book Value 119.08 119.61 122.22 111.45 98.13 83.44
Book Value(Adj)-Unit Curr 119.08 119.61 122.22 111.45 98.13 83.44

Shareholding Pattern

  • Promoter Group

    58.86%

  • Public Share Holding

    41.00%

  • Custodian

    0.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 20,060,167 21.73 20,060,167 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 34,273,082 37.13 34,273,082 7
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 54,333,249 58.86 54,333,249 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,176,394 1.27 1,176,394 34
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 15,834,938 17.16 15,834,938 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 483,873 0.52 483,873 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 17,495,205 18.95 17,495,205 45
2] Non Institution
Bodies Corporate 2,416,033 2.62 2,416,033 154
Clearing Members 36,522 0.04 36,522 22
Directors of their Relatives 1,140,500 1.24 1,140,500 6
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 642,184 0.70 642,184 811
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 410,594 0.44 410,594 676
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,636,464 5.02 4,636,464 20
Individuals holding nominal share capital up to Rs. 1 lakh 10,761,547 11.66 10,529,347 30,682
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 151,099 0.16 151,099 1
Sub Total 20,345,251 22.04 20,113,051 32,399
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 129,900 0.14 129,900 1
Total Shares held by Custodians and against which Depository Receipts have been issued 129,900 0.14 129,900 1
Grand Total ( A + B + C ) 92,303,605 100.00 92,071,405 32,457

Company Background

Indoco Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Indoco Remedies Ltd
  • BSE Code : 12579.0
  • ISIN : INE873D01024

  • Incorporation Year

    1947

  • Registered Office

    Indoco House 166 C S T Road
    Santacruz (East) Kalina, Mumbai,
    Maharashtra-400098

  • Telephone

    91-022-26541851-55

  • FAX

    91-022-26520787

  • Chairman

    Suresh G Kare

  • Managing Director

    Suresh G Kare

  • Company Secretary

  • Auditor

    Gokhale & Sathe

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Indoco Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Indoco Remedies 254.05 1,715.71 1,686.07 22.38 4.23
Abbott India 25,272.60 7,217.19 6,929.05 33.26 43.78
Astrazeneca Phar 6,858.65 2,304.07 2,275.58 101.09 27.86
Glaxosmi. Pharma 2,840.80 3,932.76 3,790.20 45.38 58.17
Novartis India 2,425.05 393.10 354.33 61.24 15.94
Cipla 1,380.00 20,102.60 18,979.95 36.27 13.88
Bliss GVS Pharma 703.70 773.53 729.81 65.40 12.51
Amrutanjan Healt 493.80 520.13 502.55 26.45 24.16
Fermenta Biotec. 483.30 474.15 450.25 22.56 18.77
Guj. Themis Bio. 430.80 168.25 165.82 115.19 18.05
Ambalal Sarabhai 41.45 19.52 3.94 76.76 6.77